Emergency room physician and former U.S. Marine and Navy Commander Dr. Richard McCormick discusses the progress being made on the coronavirus pandemic.
Regeneron Pharmaceutical shares soared Tuesday morning after the drugmaker said it hopes to begin clinical trials for a new coronavirus treatment as soon as this summer.
Continue Reading Below
Shares of the Tarrytown, New York-based company gained as much as 15 percent ahead of the opening bell.
| Ticker | Security | Last | Change | Change % |
|---|---|---|---|---|
| REGN | REGENERON PHARMACEUTICALS INC. | 440.83 | -24.72 | -5.31% |
“Given the tremendous interest and concern around the COVID-19 pandemic, we will be providing regular and transparent updates on our discovery and development programs,” Dr. George D. Yancopoulos, cofounder and chief scientific officer, said in a statement.
This story is developing. Check back for updates.
